John P Bois1, Cynthia S Crowson2, Tamanna Khullar1, Sara J Achenbach2, Megan L Krause3, Rekha Mankad1. 1. Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA. 2. Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA. 3. Division of Allergy, Clinical Immunology, and Rheumatology, University of Kansas, Kansas City, Kansas.
Abstract
OBJECTIVE: Valvular heart disease is common in patients with rheumatoid arthritis (RA). However, there is uncertainty about how often to perform echocardiographic surveillance in this population. The objective of this study was to assess the progression rate of mild and moderate aortic stenosis (AS) in patients with RA. METHODS: A population-based cohort of patients with RA and either mild (2.0-2.9 m/second) or moderate (3.0-3.9 m/second) AS was identified. Demographic, clinical, and echocardiographic data were collected. Annual progression rate of AS was then calculated for the study cohort and the impact of pertinent RA variables on progression rate determined. RESULTS: Sixty-eight patients with RA and mild or moderate AS met the inclusion requirements. Peak aortic valve (AV) velocity and mean AV gradient increased during the study period, whereas AV area decreased, consistent with progression of AS (P<.001). Mean (SD) annual increase in peak AV jet velocity was 0.05 m/second (0.01) and in mean AV gradient was 1.0 mm Hg (0.18). Mean annual decrease in AV area was 0.04 (0.01) cm2 . The progression rate of AS was higher in patients with increased erythrocyte sedimentation rates (ESR) (P=.001). CONCLUSIONS: The rate of AS progression in the RA population was higher in patients with increased ESR but less than that of the reported rate of AS progression in the general population. Although the cause for this finding is uncertain, these results suggest that patients with RA who have mild or moderate AS should undergo echocardiographic surveillance for disease progression similar to that of the general population.
OBJECTIVE:Valvular heart disease is common in patients with rheumatoid arthritis (RA). However, there is uncertainty about how often to perform echocardiographic surveillance in this population. The objective of this study was to assess the progression rate of mild and moderate aortic stenosis (AS) in patients with RA. METHODS: A population-based cohort of patients with RA and either mild (2.0-2.9 m/second) or moderate (3.0-3.9 m/second) AS was identified. Demographic, clinical, and echocardiographic data were collected. Annual progression rate of AS was then calculated for the study cohort and the impact of pertinent RA variables on progression rate determined. RESULTS: Sixty-eight patients with RA and mild or moderate AS met the inclusion requirements. Peak aortic valve (AV) velocity and mean AV gradient increased during the study period, whereas AV area decreased, consistent with progression of AS (P<.001). Mean (SD) annual increase in peak AV jet velocity was 0.05 m/second (0.01) and in mean AV gradient was 1.0 mm Hg (0.18). Mean annual decrease in AV area was 0.04 (0.01) cm2 . The progression rate of AS was higher in patients with increased erythrocyte sedimentation rates (ESR) (P=.001). CONCLUSIONS: The rate of AS progression in the RA population was higher in patients with increased ESR but less than that of the reported rate of AS progression in the general population. Although the cause for this finding is uncertain, these results suggest that patients with RA who have mild or moderate AS should undergo echocardiographic surveillance for disease progression similar to that of the general population.
Authors: Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart Journal: J Am Soc Echocardiogr Date: 2005-12 Impact factor: 5.251
Authors: R C Lawrence; C G Helmick; F C Arnett; R A Deyo; D T Felson; E H Giannini; S P Heyse; R Hirsch; M C Hochberg; G G Hunder; M H Liang; S R Pillemer; V D Steen; F Wolfe Journal: Arthritis Rheum Date: 1998-05
Authors: Cynthia S Crowson; Eric L Matteson; Elena Myasoedova; Clement J Michet; Floranne C Ernste; Kenneth J Warrington; John M Davis; Gene G Hunder; Terry M Therneau; Sherine E Gabriel Journal: Arthritis Rheum Date: 2011-03
Authors: C Montecucco; G Gobbi; S Perlini; S Rossi; A M Grandi; R Caporali; G Finardi Journal: Clin Exp Rheumatol Date: 1999 Jul-Aug Impact factor: 4.473
Authors: Ivana Hollan; Pier Luigi Meroni; Joseph M Ahearn; J W Cohen Tervaert; Sam Curran; Carl S Goodyear; Knut A Hestad; Bashar Kahaleh; Marcello Riggio; Kelly Shields; Mary C Wasko Journal: Autoimmun Rev Date: 2013-03-27 Impact factor: 9.754
Authors: Reto D Kurmann; Edward A El-Am; Yasser A Radwan; Avneek S Sandhu; Cynthia S Crowson; Eric L Matteson; Kenneth J Warrington; Rekha Mankad; Ashima Makol Journal: J Rheumatol Date: 2021-01-15 Impact factor: 5.346
Authors: Christian Nitsche; Paul R Scully; Kush P Patel; Andreas A Kammerlander; Matthias Koschutnik; Carolina Dona; Tim Wollenweber; Nida Ahmed; George D Thornton; Andrew D Kelion; Nikant Sabharwal; James D Newton; Muhiddin Ozkor; Simon Kennon; Michael Mullen; Guy Lloyd; Marianna Fontana; Philip N Hawkins; Francesca Pugliese; Leon J Menezes; James C Moon; Julia Mascherbauer; Thomas A Treibel Journal: J Am Coll Cardiol Date: 2020-11-09 Impact factor: 24.094